about
Current Trends in Development of Liposomes for Targeting Bacterial BiofilmsPulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in RatsLong-term safety and efficacy of tobramycin in the management of cystic fibrosis.Generation of tailored aerosols for inhalative drug delivery employing recent vibrating-mesh nebulizer systems.Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy.New drug developments in the management of cystic fibrosis lung disease.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Inhaled liposomal amikacin.
@en
type
label
Inhaled liposomal amikacin.
@en
prefLabel
Inhaled liposomal amikacin.
@en
P2860
P1476
Inhaled liposomal amikacin
@en
P2093
Valerie Waters
P2860
P304
P356
10.1586/17476348.2014.918507
P50
P577
2014-05-31T00:00:00Z